Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial
Business

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial

April 6, 2026
Benzinga
Scroll

Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen. Importance Rank: 1 read more

Praxis Stock Rises After Elsunersen Shows 77% Seizure Reduction In Trial
Read Full Article
Benzinga
Benzinga

Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.

United States of America
Bias: center
You might also like

Explore More